Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
AIDS Research and Human Retroviruses|August 24, 2000
HIV type 1 protease cleavage site mutations and viral fitness: implications for drug susceptibility phenotyping assaysL H Robinson, R E Myers, B W Snowden, et al.Antimicrobial Agents and Chemotherapy|February 24, 2006
In vitro development of resistance to human immunodeficiency virus protease inhibitor GW640385P J Yates, R Hazen, M St Clair, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2000
A novel genotype encoding a single amino acid insertion and five other substitutions between residues 64 and 74 of the HIV-1 reverse transcriptase confers high-level cross-resistance to nucleoside reverse transcriptase inhibitors. Abacavir CNA2007 International Study GroupA Rakik, M Ait-Khaled, P Griffin, et al.AIDS (London, England)|July 14, 2000
Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studiesM Maguire, M Gartland, S Moore, et al.Journal of Virology|October 1, 1988
Characterization of human immunodeficiency virus type 1 reverse transcriptase by using monoclonal antibodies: role of the C terminus in antibody reactivity and enzyme functionM Tisdale, P Ertl, B A Larder, et al.Antimicrobial Agents and Chemotherapy|August 1, 1995
Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitorsM Tisdale, R E Myers, B Maschera, et al.Analytical Biochemistry|May 3, 2000
Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivirR C Buxton, B Edwards, R R Juo, et al.Journal of Virology|July 25, 2000
Structural and kinetic analyses of the protease from an amprenavir-resistant human immunodeficiency virus type 1 mutant rendered resistant to saquinavir and resensitized to amprenavirW Markland, B G Rao, J D Parsons, et al.The Journal of Infectious Diseases|March 18, 2000
Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative GroupP R Harrigan, C Stone, P Griffin, et al.Virology|December 22, 1999
In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivirJ M Barnett, A Cadman, F M Burrell, et al.Pageof 5